West Pharmaceutical Services Inc. Stock
West Pharmaceutical Services Inc. gained 0.430% compared to yesterday.
The stock is an absolute favorite of our community with 21 Buy predictions and no Sell predictions.
On the other hand, the target price of 301 € is below the current price of 302.0 € for West Pharmaceutical Services Inc., so the potential is actually -0.33%.
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | 0.430% | -1.372% | -3.576% | 42.790% | 28.895% | -16.227% | -17.935% |
| Haemonetics Corp. | 3.290% | 7.432% | 16.912% | - | 16.058% | - | - |
| Bio-Rad Labs Inc. A | 0.840% | 5.716% | 26.570% | 38.502% | 21.908% | -13.293% | -52.364% |
| Penumbra Inc | -0.490% | 0.932% | 1.734% | 30.129% | 5.706% | 21.379% | 28.584% |
Comments
West Pharmaceutical Services (WST) had its "buy" rating reaffirmed by Citigroup Inc..
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (WST) had its "outperform" rating reaffirmed by Evercore Inc.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (WST) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for WST provided by MarketBeat